222 related articles for article (PubMed ID: 34099636)
1. Oxytocin receptor induces mammary tumorigenesis through prolactin/p-STAT5 pathway.
Li D; San M; Zhang J; Yang A; Xie W; Chen Y; Lu X; Zhang Y; Zhao M; Feng X; Zheng Y
Cell Death Dis; 2021 Jun; 12(6):588. PubMed ID: 34099636
[TBL] [Abstract][Full Text] [Related]
2. OXTR overexpression leads to abnormal mammary gland development in mice.
Li D; Ji Y; Zhao C; Yao Y; Yang A; Jin H; Chen Y; San M; Zhang J; Zhang M; Zhang L; Feng X; Zheng Y
J Endocrinol; 2018 Nov; 239(2):121-136. PubMed ID: 30089682
[TBL] [Abstract][Full Text] [Related]
3. Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis.
Mapes J; Anandan L; Li Q; Neff A; Clevenger CV; Bagchi IC; Bagchi MK
J Biol Chem; 2018 Feb; 293(8):2850-2864. PubMed ID: 29321207
[TBL] [Abstract][Full Text] [Related]
4. Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways.
Chen CC; Stairs DB; Boxer RB; Belka GK; Horseman ND; Alvarez JV; Chodosh LA
Genes Dev; 2012 Oct; 26(19):2154-68. PubMed ID: 23028142
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
[TBL] [Abstract][Full Text] [Related]
6. Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity.
Zhao D; Ma G; Zhang X; He Y; Li M; Han X; Fu L; Dong XY; Nagy T; Zhao Q; Fu L; Dong JT
J Biol Chem; 2016 Jun; 291(24):12809-12820. PubMed ID: 27129249
[TBL] [Abstract][Full Text] [Related]
7. Stathmin Is Required for Normal Mouse Mammary Gland Development and Δ16HER2-Driven Tumorigenesis.
Segatto I; Zompit MM; Citron F; D'Andrea S; Vinciguerra GLR; Perin T; Berton S; Mungo G; Schiappacassi M; Marchini C; Amici A; Vecchione A; Baldassarre G; Belletti B
Cancer Res; 2019 Jan; 79(2):397-409. PubMed ID: 30478213
[TBL] [Abstract][Full Text] [Related]
8. Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors.
Guigon CJ; Kim DW; Willingham MC; Cheng SY
Oncogene; 2011 Jul; 30(30):3381-90. PubMed ID: 21399657
[TBL] [Abstract][Full Text] [Related]
9. Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis.
Schmidt JW; Wehde BL; Sakamoto K; Triplett AA; Anderson SM; Tsichlis PN; Leone G; Wagner KU
Mol Cell Biol; 2014 Apr; 34(7):1363-77. PubMed ID: 24469394
[TBL] [Abstract][Full Text] [Related]
10. Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.
Vomachka AJ; Pratt SL; Lockefeer JA; Horseman ND
Oncogene; 2000 Feb; 19(8):1077-84. PubMed ID: 10713693
[TBL] [Abstract][Full Text] [Related]
11. Prolactin inhibits cell loss and decreases matrix metalloproteinase expression in the involuting mouse mammary gland but fails to prevent cell loss in the mammary glands of mice expressing IGFBP-5 as a mammary transgene.
Flint DJ; Boutinaud M; Whitelaw CB; Allan GJ; Kolb AF
J Mol Endocrinol; 2006 Jun; 36(3):435-48. PubMed ID: 16720715
[TBL] [Abstract][Full Text] [Related]
12. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
13. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.
Sakamoto K; Triplett AA; Schuler LA; Wagner KU
Oncogene; 2010 Sep; 29(39):5359-69. PubMed ID: 20639901
[TBL] [Abstract][Full Text] [Related]
14. Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium.
Tarulli GA; De Silva D; Ho V; Kunasegaran K; Ghosh K; Tan BC; Bulavin DV; Pietersen AM
Breast Cancer Res; 2013 Jan; 15(1):R10. PubMed ID: 23369183
[TBL] [Abstract][Full Text] [Related]
15. Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells.
Qian L; Lopez V; Seo YA; Kelleher SL
Am J Physiol Cell Physiol; 2009 Aug; 297(2):C369-77. PubMed ID: 19494234
[TBL] [Abstract][Full Text] [Related]
16. Prolactin regulates LAT1 expression via STAT5 (signal transducer and activator of transcription 5) signaling in mammary epithelial cells of dairy cows.
Zhou J; Jiang M; Shi Y; Song S; Hou X; Lin Y
J Dairy Sci; 2020 Jul; 103(7):6627-6634. PubMed ID: 32389479
[TBL] [Abstract][Full Text] [Related]
17. PTHrP induces STAT5 activation, secretory differentiation and accelerates mammary tumor development.
Grinman DY; Boras-Granic K; Takyar FM; Dann P; Hens JR; Marmol C; Lee J; Choi J; Chodosh LA; Sola MEG; Wysolmerski JJ
Breast Cancer Res; 2022 Apr; 24(1):30. PubMed ID: 35440032
[TBL] [Abstract][Full Text] [Related]
18. Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.
Manhès C; Kayser C; Bertheau P; Kelder B; Kopchick JJ; Kelly PA; Touraine P; Goffin V
J Endocrinol; 2006 Aug; 190(2):271-85. PubMed ID: 16899561
[TBL] [Abstract][Full Text] [Related]
19. A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis.
Dearth RK; Kuiatse I; Wang YF; Liao L; Hilsenbeck SG; Brown PH; Xu J; Lee AV
BMC Cancer; 2011 Aug; 11():377. PubMed ID: 21867536
[TBL] [Abstract][Full Text] [Related]
20. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.
Nevalainen MT; Xie J; Bubendorf L; Wagner KU; Rui H
Mol Endocrinol; 2002 May; 16(5):1108-24. PubMed ID: 11981045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]